The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Immunoregulatory Cytokines in Chronic Hepatitis C Virus Infection: Pre– and Posttreatment With Interferon Alfa
Open accessAbstract
T lymphocytes and immunoregulatory cytokines may be important in the host response to hepatitis C virus (HCV) infection. T–helper type 1 (Th1) cytokines (interleukin [IL]–2, interferon gamma [IFN–gamma]) are required for host antiviral immune responses, including cytotoxic T–cell generation and natural killer cell activation, while T–helper type 2 (Th2) cytokines (IL–4,IL–10) can inhibit the development of these effector mechanisms. In this study, the serum levels of Th1 and Th2 cytokines in patients (n = 23) infected with HCV were measured and compared with biochemical (alanine transaminase [ALT]) and viral (HCV RNA) indicators of infection. Serial cytokine levels were measured in a subset of 11 patients at 1 and 12 weeks during and at 1 week after interferon alfa (IFN–α) therapy (n = 33 samples). Levels of circulating IL–2, IL–4, IL–10, and IFN–γ were significantly elevated in HCV patients versus normal controls (128 vs. 25 pg/mL, 3,045 vs. 29 pg/mL, 2,949 vs. 18 pg/mL, and 307 vs. 24 pg/mL respectively; P < .01). Treatment with IFN–α decreased the levels of IL–4 (321 ± 224 pg/mL), and IL–10 (1,011 ± 344 pg/mL), which paralleled a decrease in HCV RNA (114 ± 27 vs. 25 ± 20 Eq/ml X 105, pre– vs. post–IFN–α [12 weeks]; P <.05). These findings indicate that an activated T–cell response, as manifest by increased circulating immunoregulatory cytokines, is present in patients with HCV liver disease. Furthermore, treatment with HCV liver disease. Furthermore, treatment with IFN–α diminishes the Th2 cytokine response. Thus, modulation of T–cell function and cytokine production may be one mechanism whereby IFN–α therapy results in reduced viral burden.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
Choo, Q.-L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W., & Houghton, M. (1989) · Science · doi:10.1126/science.2523562 · Cited by 6,875
Nathan, C. F., Murray, H. W., Wiebe, M. E., & Rubin, B. Y. (1983) · The Journal of experimental medicine · doi:10.1084/jem.158.3.670 · Cited by 1,962
de Waal Malefyt, R., Haanen, J., Spits, H., Roncarolo, M. G., te Velde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.4.915 · Cited by 1,930
IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.10.3444 · Cited by 1,865
The Natural History of Community-Acquired Hepatitis C in the United States
Alter, M. J., Margolis, H. S., Krawczynski, K., Judson, F. N., Mares, A., Alexander, W. J., Hu, P. Y., Miller, J. K., Gerber, M. A., Sampliner, R. E., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272702 · Cited by 1,592
Recombinant Interferon Alfa Therapy for Chronic Hepatitis C
Di Bisceglie, A. M., Martin, P., Kassianides, C., Lisker-Melman, M., Murray, L., Waggoner, J., Goodman, Z., Banks, S. M., & Hoofnagle, J. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911303212204 · Cited by 1,212
Cherwinski, H. M., Schumacher, J. H., Brown, K. D., & Mosmann, T. R. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.5.1229 · Cited by 1,036
Significance of serum hepatitis C virus RNA levels in chronic hepatitis C
Lau, J. Y. N., Davis, G. L., Kniffen, J., Qian, K.-P., Urdea, M. S., Chan, C. S., Neuwald, P. D., Wilber, J. C., & Mizokami, M. (1993) · The Lancet · doi:10.1016/0140-6736(93)90635-t · Cited by 795
Balkwill, F. R., & Burke, F. (1989) · Immunology Today · doi:10.1016/0167-5699(89)90085-6 · Cited by 783
Serum levels of cytokines in chronic liver diseases
Tilg, H., Wilmer, A., Vogel, W., Herold, M., Nölchen, B., Judmaier, G., & Huber, C. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91122-k · Cited by 739
Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy
Hagiwara, H., Hayashi, N., Mita, E., Takehara, T., Kasahara, A., Fusamoto, H., & Kamada, T. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)91025-d · Cited by 377
Spits, H., Yssel, H., Paliard, X., et al. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.1.29 · Cited by 163
IL-4 inhibits IL-2 receptor expression and IL-2-dependent proliferation of human T cells.
Martinez, O. M., Gibbons, R. S., Garovoy, M. R., & Aronson, F. R. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.6.2211 · Cited by 150
Self-citationNagler, A., Lanier, L. L., & Phillips, J. H. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.7.2349 · Cited by 124
Kern, D. E., Gillis, S. A., Okada, M., & Henney, C. S. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.127.4.1323 · Cited by 112
Daniels, H. M., Eddleston, A. L. W. F., Alexander, G., Williams, R. L., & Meager, A. (1990) · The Lancet · doi:10.1016/0140-6736(90)90475-k · Cited by 96
Interleukin-1 and interleukin-2 activity in chronic hepatitis B virus infection
Anastassakos, C., Alexander, G., Wolstencroft, R. A., Avery, J., Portmann, B. C., Panayi, G. S., Dumonde, D. C., Eddleston, A. L. W. F., & Williams, R. L. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90559-8 · Cited by 79
Roulot, D. M., Durand, H., Coste, T. C., Rautureau, J., Strosberg, A. D., Bénarous, R., & Marullo, S. (1995) · Hepatology · doi:10.1002/hep.1840210206 · Cited by 56
Cited by
Interleukin-10 determines viral clearance or persistence in vivo
Brooks, D. G., Trifilo, M. J., Edelmann, K. H., Teyton, L., McGavern, D. B., & Oldstone, M. B. A. (2006) · Nature Medicine · doi:10.1038/nm1492 · Cited by 923
Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease
Forton, D. M., Thomas, H. C., Murphy, C. A., Allsop, J. M., Foster, G. R., Main, J., Wesnes, K. A., & Taylor-Robinson, S. D. (2002) · Hepatology · doi:10.1053/jhep.2002.30688 · Cited by 450
Edwards-Smith, C. J., Jonsson, J. R., Purdie, D. M., Bansal, A., Shorthouse, C., & Powell, E. E. (1999) · Hepatology · doi:10.1002/hep.510300207 · Cited by 404
Mechanism of action of ribavirin in the combination treatment of chronic HCV infection
Lau, J. Y. N., Tam, R. C., Liang, J. T., & Hong, Z. (2002) · Hepatology · doi:10.1053/jhep.2002.32672 · Cited by 337
Features of responding T cells in cancer and chronic infection
Kim, P. S., & Ahmed, R. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.02.005 · Cited by 297
Metadata
- Authors
- Cacciarelli, T. V., Martinez, O. M., Gish, R. G., Villanueva, J. C., & Krams, S. M.
- Venue
- Hepatology
- Published
- 1996-07
- Volume
- 24
- Issue
- 1
- Pages
- 6-9
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2030380453
- Cited by
- 284
- References
- 19
- FWCI
- 10.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.